13F Filings History of Avoro Capital Advisors LLC
- Latest 13F filing
- Q1 2026 - 15 May 2026
- Latest reported 13F value
- $10,151,443,055
- Largest 13F holdings
-
UTHR ASND MDGL KRYS ARGX ARWR KYMR APLS CNTA CELC XENE GPCR
+8 more
TERN VERA RVMD CYTK OCUL DMRA QURE TSHA - Form 13F summary
-
- Avoro Capital Advisors LLC Form 13F history summarizes parsed U.S.-listed equity disclosures for this manager.
- Form 13F is generally due within 45 days after each calendar quarter ends.
- Avoro Capital Advisors LLC reported 30 equity holdings with a total reported market value of $10,151,443,055 for Q1 2026. Top reported holdings included UTHR, ASND, MDGL, KRYS, and ARGX.
- Manager signature
- Scott Epstein - Chief Compliance Officer & COO
- Manager location
- New York, NY
13F snapshot
Latest parsed holdings, value, and filing-period context.
1 signal
Manager
Names, identifiers, and filing context for this profile.
2 identity fields
Follow Filing Activity
Follow Avoro Capital Advisors LLC with Pro and return when a new 13F portfolio filing changes the record on this page.
Pro alert delivery is coming soon and remains tied to source-backed filing changes rather than inferred market advice.
Holdings Value
Form 13F evidence
Quarterly portfolio filings
SEC-reported 13F quarters for this filer, ordered by the latest accepted filing.
Latest quarter
Q1 2026
Latest value
$10,151,443,055
Quarter delta
-$22,308,377
Accepted
15 May 2026, 06:53
Rows shown
1-25 of 46
| Quarter | Holdings | SEC-reported value | Bought | Sold | Net | Top Holdings | Form Type | Accepted by SEC |
|---|---|---|---|---|---|---|---|---|
| Q1 2026 | 30 | $10,151,443,055 | +$616,583,001 | -$1,039,191,511 | -$422,608,510 | UTHR, ASND, MDGL, KRYS, ARGX | 13F-HR | 15 May 2026, 06:53 |
| Q4 2025 | 33 | $10,173,751,432 | +$1,841,253,130 | -$1,115,245,802 | +$726,007,328 | UTHR, ASND, MDGL, ARGX, KRYS | Restatement | 13 Mar 2026, 19:48 |
| Q3 2025 | 30 | $7,729,823,545 | +$575,094,026 | -$488,687,315 | +$86,406,711 | ASND, UTHR, MDGL, ARGX, KRYS | 13F-HR | 14 Nov 2025, 07:10 |
| Q2 2025 | 30 | $5,710,277,507 | +$333,847,805 | -$1,135,122,878 | -$801,275,073 | ASND, UTHR, ARGX, MDGL, KRYS | 13F-HR | 14 Aug 2025, 08:00 |
| Q1 2025 | 33 | $6,406,567,714 | +$441,319,280 | -$619,061,424 | -$177,742,144 | UTHR, ASND, ARGX, MDGL, KRYS | 13F-HR | 15 May 2025, 06:55 |
| Q4 2024 | 39 | $7,069,981,381 | +$537,904,563 | -$168,298,472 | +$369,606,091 | UTHR, ARGX, ASND, MDGL, KRYS | 13F-HR | 14 Feb 2025, 08:34 |
| Q3 2024 | 35 | $6,858,026,355 | +$301,228,516 | -$1,128,358,712 | -$827,130,196 | UTHR, ASND, ARGX, KRYS, MDGL | 13F-HR | 14 Nov 2024, 07:59 |
| Q2 2024 | 41 | $7,508,400,483 | +$255,296,045 | -$1,179,503,359 | -$924,207,314 | UTHR, MDGL, ASND, ARGX, SRPT | 13F-HR | 14 Aug 2024, 07:58 |
| Q1 2024 | 46 | $8,573,512,829 | +$1,703,672,329 | -$873,497,371 | +$830,174,958 | UTHR, APLS, ASND, SRPT, MDGL | 13F-HR | 15 May 2024, 08:07 |
| Q4 2023 | 42 | $7,239,756,496 | +$1,496,505,071 | -$1,480,185,579 | +$16,319,492 | APLS, UTHR, ASND, ARGX, MDGL | 13F-HR | 14 Feb 2024, 12:05 |
| Q3 2023 | 45 | $6,409,999,031 | +$265,707,460 | -$764,094,775 | -$498,387,315 | HZNP, UTHR, ARGX, SRPT, APLS | 13F-HR | 14 Nov 2023, 06:32 |
| Q2 2023 | 43 | $7,371,201,102 | +$486,142,261 | -$166,011,824 | +$320,130,437 | APLS, HZNP, UTHR, SRPT, ARGX | 13F-HR | 14 Aug 2023, 07:33 |
| Q1 2023 | 38 | $6,739,485,093 | +$304,214,023 | -$21,427,488 | +$282,786,535 | HZNP, APLS, UTHR, SRPT, ARGX | 13F-HR | 15 May 2023, 09:09 |
| Q4 2022 | 36 | $6,691,518,386 | +$472,698,953 | -$55,749,735 | +$416,949,218 | UTHR, HZNP, APLS, MDGL, ARGX | 13F-HR | 14 Feb 2023, 09:04 |
| Q3 2022 | 39 | $5,412,850,000 | +$264,383,922 | -$195,536,506 | +$68,847,416 | APLS, UTHR, ARGX, MRTX, SRPT | 13F-HR | 14 Nov 2022, 09:28 |
| Q2 2022 | 40 | $5,060,568,000 | +$321,859,556 | -$394,859,197 | -$72,999,641 | UTHR, ARGX, APLS, HZNP, MRTX | 13F-HR | 15 Aug 2022, 08:54 |
| Q1 2022 | 43 | $5,477,565,000 | +$788,768,564 | -$411,273,703 | +$377,494,861 | HZNP, UTHR, APLS, MRTX, ARGX | 13F-HR | 16 May 2022, 08:57 |
| Q4 2021 | 40 | $5,862,620,000 | +$640,422,254 | -$1,229,129,998 | -$588,707,744 | HZNP, MRTX, UTHR, APLS, ARGX | 13F-HR | 14 Feb 2022, 09:03 |
| Q3 2021 | 43 | $6,338,733,000 | +$602,993,544 | -$363,618,520 | +$239,375,024 | HZNP, MRTX, XLRN, UTHR, ASND | 13F-HR | 15 Nov 2021, 09:04 |
| Q2 2021 | 44 | $5,743,703,000 | +$644,089,572 | -$497,541,121 | +$146,548,451 | HZNP, MRTX, UTHR, XLRN, ARGX | 13F-HR | 16 Aug 2021, 09:05 |
| Q1 2021 | 46 | $5,790,264,000 | +$1,094,159,675 | -$373,203,423 | +$720,956,252 | HZNP, MRTX, UTHR, XLRN, VRTX | 13F-HR | 17 May 2021, 09:29 |
| Q4 2020 | 43 | $5,806,497,000 | +$1,137,373,807 | -$3,071,981,534 | -$1,934,607,727 | MRTX, HZNP, UTHR, IOVA, ARNA | 13F-HR | 16 Feb 2021, 12:33 |
| Q3 2020 | 46 | $7,038,431,000 | +$727,334,026 | -$353,003,695 | +$374,330,331 | IMMU, MRTX, HZNP, IOVA, ASND | 13F-HR | 16 Nov 2020, 09:02 |
| Q2 2020 | 44 | $5,057,950,000 | +$742,808,471 | -$192,987,946 | +$549,820,525 | IMMU, MRTX, HZNP, IOVA, SRPT | 13F-HR | 14 Aug 2020, 10:00 |
| Q1 2020 | 41 | $2,959,530,000 | +$489,259,712 | -$50,671,102 | +$438,588,610 | IMMU, MRTX, IOVA, ASND, BMRN | 13F-HR | 15 May 2020, 13:03 |